443.90
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALNY Giù?
Forum
Previsione
Alnylam Pharmaceuticals Inc Borsa (ALNY) Ultime notizie
Alnylam receives subpoena from US Attorney's Office amid strong Q3 earnings - The Business Journals
Alnylam (ALNY) Reports Strong Q3 Revenues and Raises Future Guidance - GuruFocus
Compared to Estimates, Alnylam (ALNY) Q3 Earnings: A Look at Key Metrics - Yahoo! Finance Singapore
Alnylam Pharmaceuticals, Inc. Revises Earnings Guidance for the Year 2025 - MarketScreener
Alnylam Pharmaceuticals : Q3 2025 Earnings Presentation - MarketScreener
Alnylam Pharmaceuticals Surpasses Q3 2025 Estimates with $1.84 E - GuruFocus
Alnylam Pharma shares fall 4% despite strong Q3 results and raised guidance - Investing.com Canada
Alnylam Pharmaceuticals Swings to Q3 Non-GAAP Earnings, Revenue Increases - MarketScreener
Alnylam: Q3 Earnings Snapshot - News-Times
ALNYLAM PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress - Business Wire
Why global investors buy Alnylam Pharmaceuticals Inc. (DUL) stockWeekly Stock Analysis & AI Optimized Trading Strategy Guides - newser.com
How dovish Fed policy supports Alnylam Pharmaceuticals Inc. (DUL) stock2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Is Alnylam Pharmaceuticals Inc. reversing from oversold territoryProduct Launch & Reliable Entry Point Alerts - newser.com
Alnylam Pharmaceuticals, Inc. $ALNY Shares Bought by Teacher Retirement System of Texas - MarketBeat
Combining machine learning predictions for Alnylam Pharmaceuticals Inc.Trade Risk Summary & Technical Buy Zone Confirmations - newser.com
How to recover losses in Alnylam Pharmaceuticals Inc. stockPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
Is Alnylam Pharmaceuticals Inc. (DUL) stock vulnerable to rate hikesWatch List & Free Expert Verified Stock Movement Alerts - newser.com
Amgen's Q3 Earnings in the Cards: Here's What to Expect - The Globe and Mail
How Recent Momentum and Analyst Upgrades Are Shaping Alnylam’s Evolving Investment Story - Yahoo Finance
How to monitor Alnylam Pharmaceuticals Inc. with trend dashboardsQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
What data driven models say about Alnylam Pharmaceuticals Inc.’s futureJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
RNAi Technology Market See Incredible Growth 2025-2032 | Alnylam Pharmaceuticals, OriGene Technologies, Inc. - openPR.com
Motley Fool Asset Management LLC Grows Stock Holdings in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Alnylam Pharmaceuticals, Inc. $ALNY Shares Acquired by Wealthfront Advisers LLC - MarketBeat
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain revenue momentumPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
How risky is Alnylam Pharmaceuticals Inc. (DUL) stock compared to peersJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Will Alnylam Pharmaceuticals Inc. continue its uptrendJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
What RSI levels show for Alnylam Pharmaceuticals Inc. (DUL) stock2025 Market WrapUp & Accurate Trade Setup Notifications - newser.com
PD-1 and PD-L1 Inhibitors Clinical Landscape, Key Companies, Therapeutic Evaluation, Treatment Approaches, and Pipeline Insights | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals - Barchart.com
Bevacizumab: Clinical Overview, Key Companies, Therapeutic Insights, Treatment Strategies, and Pipeline Analysis | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG B - Barchart.com
Why Alnylam Pharmaceuticals Inc. stock is recommended by analystsWeekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Is Alnylam Pharmaceuticals Inc. stock dividend yield sustainableQuarterly Earnings Report & Weekly High Conviction Trade Ideas - Fundação Cultural do Pará
Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS - Yahoo! Finance UK
Hypertension Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Addpharma Inc., Alnylam Therapeutics, ORPHAI THERAPEUTICS, 35Pharma Inc - Barchart.com
Alnylam Pharmaceuticals (ALNY) extending rally in final stage from April-2025 low - FXStreet
What downside risks could hit Alnylam Pharmaceuticals Inc. (DUL) stock2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
Convergence Investment Partners LLC Acquires New Position in Alnylam Pharmaceuticals, Inc. $ALNY - MarketBeat
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain institutional flows2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Is it time to cut losses on Alnylam Pharmaceuticals Inc.Treasury Yields & Smart Investment Allocation Insights - newser.com
What to do if you’re stuck in Alnylam Pharmaceuticals Inc.Trade Ideas & Weekly Top Gainers Trade List - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):